{"meta":{},"result":{"jobOpening":{"jobOpeningShareUrl":"https:\/\/orumtherapeutics.bamboohr.com\/careers\/87","jobOpeningName":"Preclinical Pharmacology and External Scientific Operations Lead (Shanghai)","jobOpeningStatus":"Open","jobCategoryId":null,"departmentId":"18578","departmentLabel":"Biology","employmentStatusLabel":"Full Time CN","location":{"city":null,"state":null,"postalCode":null,"addressCountry":null},"atsLocation":{"country":"China","countryId":"44","state":"Jiangsu","city":"Shanghai"},"description":"<p><span style=\"text-decoration: underline\"><span style=\"font-size: 14pt; font-weight: bold\">Position Overview<\/span><\/span><\/p>\n<p>Orum Therapeutics is pioneering the next generation of precision medicine by combining targeted protein degradation (TPD) with antibody specificity. As our first scientific operations hire in China, you will serve as the <span style=\"font-weight: bold\">technical and cultural bridge<\/span> between our Lexington\/Daejeon hubs and Chinese vendor\/CRO partners in preclinical development activities. Through management of these external resources and application of your preclinical pharmacology expertise in collaboration with internal teams, you will drive scientific rigor, operational excellence, and strategic advancement of Orum projects and programs. As such, you will support the external preclinical development of Orum\u2019s Degrader-Antibody Conjugate (DAC) pipeline, including the lead GSPT1-directed programs and novel payload discovery efforts.<\/p>\n<p><br><\/p>\n<p><span style=\"font-weight: bold\"><span style=\"text-decoration: underline\"><span style=\"font-size: 14pt\">Key Responsibilities<\/span><\/span><br><\/span><span style=\"font-weight: bold\"><br><\/span><\/p>\n<ul>\n<li><span style=\"font-weight: bold\"><span style=\"font-weight: bold\">Vendor Scouting &amp; Selection<\/span><span style=\"font-size: 12pt; font-weight: 400\">:<\/span><\/span><\/li>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>In collaboration with project and\/or program teams, identify, evaluate, negotiate, select, and onboard specialized vendors and\/or CROs with capabilities in areas such as\u00a0<em>in vitro <\/em>activity assays, <em>in vivo<\/em> efficacy and toxicology studies, linker-payload synthesis, complex bioconjugation, and other preclinical studies.<\/li>\n<li>Ensure adherence to project and\/or program timelines, budgets, and quality standards.\u00a0 \u00a0<\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: bold\">Strategic Vendor Oversight<\/span>:\n<ul>\n<li>Leverage the global vendor\/CRO ecosystem, particularly in China, to optimize cost-effective, high-quality R&amp;D solutions while maintaining rigorous scientific oversight, data integrity, and IP protection.<\/li>\n<li>Serve as the primary liaison between internal project and\/or program teams and external partners to align priorities, timing, and deliverables.<\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: bold\">Pharmacology Leadership and Preclinical Studies Oversight:<\/span>\u00a0\n<ul>\n<li>Provide preclinical pharmacology expertise to cross-functional development of projects and\/or programs<\/li>\n<li>Oversee <em>in vivo<\/em> preclinical studies (e.g., PK, efficacy, toxicology)\u00a0 using validated, well characterized models (CDX, PDX, humanized mice) to evaluate DAC candidates for oncology and autoimmune indications.<\/li>\n<li>Guide vendor\/CRO execution to ensure studies are scientifically rigorous, robust, and strategically aligned with early research and IND-enabling programs.<\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: bold\">Platform Support &amp; External Capability Expansion:<\/span>\n<ul>\n<li>Contribute to the advancement of Orum\u2019s TPD\u00b2\u00ae platform by developing partnerships with external organizations in China that provide specialized computational and experimental capabilities, including physics-based modeling, AI\/ML-driven drug design, and advanced research workflows.<\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: bold\">Audit Coordination &amp; Compliance Facilitation<\/span>:\n<ul>\n<li>Coordinate GLP\/GMP audits of vendors\/CROs, managing communication, schedules, documentation, and follow-up actions.<\/li>\n<li>Serve as the liaison between Orum teams, external partners, and auditors to ensure smooth GLP\/GMP audits.<\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: bold\">Intellectual Property &amp; Legal Collaboration:<\/span>\n<ul>\n<li>Partner with legal and program teams to implement agreements that safeguard Orum\u2019s proprietary platforms, ensuring clear data ownership and compliance with China-specific IP regulations.<\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: bold\">Cross-Border Leadership &amp; Communication<\/span>:\n<ul>\n<li>Represent Orum as a senior authority, guiding large external vendor\/CRO teams, bridging global and local stakeholders, and ensuring seamless collaboration across R&amp;D hubs.<\/li>\n<li>Serve as the go-to person for drug development involving Chinese vendor\/CRO resources.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p><br><br><\/p>\n<p><span style=\"text-decoration: underline\"><span style=\"font-size: 14pt; font-weight: bold\">Required Qualifications &amp; Skills<\/span><\/span><\/p>\n<ul>\n<li><span style=\"font-weight: bold\">Experience:<\/span> 7\u201310+ years in biotech\/pharma, with demonstrated expertise in managing complex therapeutic modalities (e.g., DACs, ADCs, TPDs) and coordinating external development programs.<\/li>\n<li><span style=\"font-weight: bold\">Pharmacology Expertise:<\/span> Proven track record in preclinical pharmacology, including oversight of <em>in vivo<\/em> efficacy and toxicology studies using molecularly characterized CDX, PDX, or humanized mouse models for oncology or autoimmune programs.<\/li>\n<li><span style=\"font-weight: bold\">Scientific Knowledge:<\/span> Solid understanding of targeted protein degradation mechanisms, E3 ubiquitin ligase biology, and antibody-mediated intracellular delivery.<\/li>\n<li><span style=\"font-weight: bold\">Operational &amp; CRO Management:<\/span> Skilled in coordinating cross-border projects, managing vendor\/CRO partners, negotiating timelines and budgets, and ensuring scientific quality and compliance.<\/li>\n<li><span style=\"font-weight: bold\">International &amp; Local Experience:<\/span> Combines international scientific training (U.S.\/Europe) with substantial operational experience in the Chinese vendor\/CRO and regulatory landscape.<\/li>\n<li><span style=\"font-weight: bold\">Language Skills:<\/span> Fluent in Mandarin and English, both oral and written, to engage local partners and communicate with global leadership, project and program teams.<\/li>\n<li><span style=\"font-weight: bold\">Education:<\/span> PhD in Pharmacology, Biology, Organic\/Medicinal Chemistry, or a related field.<\/li>\n<\/ul>\n<p><br><\/p>\n<p><span style=\"text-decoration: underline\"><span style=\"font-size: 14pt; font-weight: bold\">Cultural &amp; Operational Perks<\/span><\/span><\/p>\n<ul>\n<li><span style=\"font-weight: bold\">Influential Leadership:<\/span> Represent Orum as a senior authority, providing guidance and oversight for large-scale external teams and CRO partnerships.<\/li>\n<li><span style=\"font-weight: bold\">Modern Work Infrastructure:<\/span> Full home-office setup stipend to enable seamless virtual collaboration with global R&amp;D leadership and cross-functional teams.<\/li>\n<\/ul>\n<p><br><\/p>\n<p><span style=\"color: rgb(224, 62, 45); font-size: 18pt; font-weight: bold\">PLEASE SUBMIT RESUME IN ENGLISH<\/span><\/p>","compensation":null,"datePosted":"2026-02-11","minimumExperience":"Senior Manager\/Supervisor","locationType":"1","seekPromoted":false},"formFields":{"firstName":{"isRequired":true,"value":"","label":"First Name"},"lastName":{"isRequired":true,"value":"","label":"Last Name"},"email":{"isRequired":true,"value":"","label":"Email"},"phone":{"isRequired":true,"value":"","label":"Phone"},"streetAddress":{"isRequired":true,"value":"","label":"Address"},"city":{"isRequired":true,"value":"","label":"City"},"state":{"isRequired":true,"value":"","label":"State","options":[]},"zip":{"isRequired":true,"value":"","label":"ZIP"},"countryId":{"isRequired":true,"value":"","label":"Country","options":[{"id":"1","text":"United States"},{"id":"2","text":"Canada"},{"id":"3","text":"Australia"},{"id":"4","text":"Afghanistan"},{"id":"5","text":"Albania"},{"id":"6","text":"Algeria"},{"id":"7","text":"American Samoa"},{"id":"8","text":"Andorra"},{"id":"9","text":"Anguilla"},{"id":"10","text":"Angola"},{"id":"11","text":"Antarctica"},{"id":"12","text":"Antigua and Barbuda"},{"id":"13","text":"Argentina"},{"id":"14","text":"Armenia"},{"id":"15","text":"Aruba"},{"id":"16","text":"Austria"},{"id":"17","text":"Azerbaijan"},{"id":"18","text":"Bahamas"},{"id":"19","text":"Bahrain"},{"id":"20","text":"Bangladesh"},{"id":"21","text":"Barbados"},{"id":"22","text":"Belgium"},{"id":"23","text":"Belize"},{"id":"24","text":"Benin"},{"id":"25","text":"Bermuda"},{"id":"26","text":"Bhutan"},{"id":"27","text":"Bolivia"},{"id":"28","text":"Bosnia and Herzegovina"},{"id":"29","text":"Botswana"},{"id":"30","text":"Bouvet Island"},{"id":"31","text":"Brazil"},{"id":"32","text":"British Indian Ocean Territory"},{"id":"33","text":"Brunei Darussalam"},{"id":"34","text":"Bulgaria"},{"id":"35","text":"Burkina Faso"},{"id":"36","text":"Burundi"},{"id":"37","text":"Cambodia"},{"id":"38","text":"Cameroon"},{"id":"39","text":"Cape Verde"},{"id":"40","text":"Cayman Islands"},{"id":"41","text":"Central African Republic"},{"id":"42","text":"Chad"},{"id":"43","text":"Chile"},{"id":"44","text":"China"},{"id":"45","text":"Christmas Island"},{"id":"46","text":"Cocos (Keeling Islands)"},{"id":"47","text":"Colombia"},{"id":"48","text":"Comoros"},{"id":"49","text":"Congo"},{"id":"50","text":"Cook Islands"},{"id":"51","text":"Costa Rica"},{"id":"52","text":"Cote D'Ivoire (Ivory Coast)"},{"id":"53","text":"Croatia (Hrvatska)"},{"id":"54","text":"Cuba"},{"id":"55","text":"Cyprus"},{"id":"56","text":"Czech Republic"},{"id":"57","text":"Denmark"},{"id":"58","text":"Djibouti"},{"id":"59","text":"Dominica"},{"id":"60","text":"Dominican Republic"},{"id":"61","text":"East Timor"},{"id":"62","text":"Egypt"},{"id":"63","text":"El Salvador"},{"id":"64","text":"Ecuador"},{"id":"65","text":"Equatorial Guinea"},{"id":"66","text":"Eritrea"},{"id":"67","text":"Estonia"},{"id":"68","text":"Ethiopia"},{"id":"69","text":"Falkland Islands (Malvinas)"},{"id":"70","text":"Faroe Islands"},{"id":"71","text":"Fiji"},{"id":"72","text":"Finland"},{"id":"73","text":"France"},{"id":"74","text":"France, Metropolitan"},{"id":"75","text":"French Guiana"},{"id":"76","text":"French Polynesia"},{"id":"77","text":"French Southern Territories"},{"id":"78","text":"French West Indies"},{"id":"79","text":"Gabon"},{"id":"80","text":"Gambia"},{"id":"81","text":"Georgia"},{"id":"82","text":"Germany"},{"id":"83","text":"Ghana"},{"id":"84","text":"Gibraltar"},{"id":"85","text":"Greece"},{"id":"86","text":"Greenland"},{"id":"87","text":"Grenada"},{"id":"88","text":"Guadeloupe"},{"id":"89","text":"Guam"},{"id":"90","text":"Guatemala"},{"id":"91","text":"Guinea"},{"id":"92","text":"Guinea-Bissau"},{"id":"93","text":"Guyana"},{"id":"94","text":"Haiti"},{"id":"95","text":"Heard and McDonald Islands"},{"id":"96","text":"Honduras"},{"id":"97","text":"Hong Kong"},{"id":"98","text":"Hungary"},{"id":"99","text":"Iceland"},{"id":"100","text":"India"},{"id":"101","text":"Indonesia"},{"id":"102","text":"Iran"},{"id":"103","text":"Iraq"},{"id":"104","text":"Ireland"},{"id":"105","text":"Israel"},{"id":"106","text":"Italy"},{"id":"107","text":"Jamaica"},{"id":"108","text":"Japan"},{"id":"109","text":"Jordan"},{"id":"110","text":"Kazakhstan"},{"id":"111","text":"Kenya"},{"id":"112","text":"Kiribati"},{"id":"113","text":"Korea (North)"},{"id":"114","text":"Korea (South)"},{"id":"115","text":"Kuwait"},{"id":"116","text":"Kyrgyzstan"},{"id":"117","text":"Laos"},{"id":"118","text":"Latvia"},{"id":"119","text":"Lebanon"},{"id":"120","text":"Lesotho"},{"id":"121","text":"Liberia"},{"id":"122","text":"Libya"},{"id":"123","text":"Liechtenstein"},{"id":"124","text":"Lithuania"},{"id":"125","text":"Luxembourg"},{"id":"126","text":"Macao"},{"id":"127","text":"Macedonia"},{"id":"128","text":"Madagascar"},{"id":"129","text":"Malawi"},{"id":"130","text":"Malaysia"},{"id":"131","text":"Maldives"},{"id":"132","text":"Mali"},{"id":"133","text":"Malta"},{"id":"134","text":"Marshall Islands"},{"id":"135","text":"Martinique"},{"id":"136","text":"Mauritania"},{"id":"137","text":"Mauritius"},{"id":"138","text":"Mayotte"},{"id":"139","text":"Mexico"},{"id":"140","text":"Micronesia"},{"id":"141","text":"Moldova"},{"id":"142","text":"Monaco"},{"id":"143","text":"Mongolia"},{"id":"144","text":"Montenegro"},{"id":"145","text":"Montserrat"},{"id":"146","text":"Morocco"},{"id":"147","text":"Mozambique"},{"id":"148","text":"Namibia"},{"id":"149","text":"Nauru"},{"id":"150","text":"Nepal"},{"id":"151","text":"Netherlands"},{"id":"152","text":"Netherlands Antilles"},{"id":"153","text":"New Caledonia"},{"id":"154","text":"New Zealand"},{"id":"155","text":"Nicaragua"},{"id":"156","text":"Niger"},{"id":"157","text":"Nigeria"},{"id":"158","text":"Niue"},{"id":"159","text":"Norfolk Island"},{"id":"160","text":"Northern Mariana Islands"},{"id":"161","text":"Norway"},{"id":"162","text":"Oman"},{"id":"163","text":"Pakistan"},{"id":"164","text":"Palau"},{"id":"165","text":"Panama"},{"id":"166","text":"Papua New Guinea"},{"id":"167","text":"Paraguay"},{"id":"168","text":"Peru"},{"id":"169","text":"Philippines"},{"id":"170","text":"Pitcairn"},{"id":"171","text":"Poland"},{"id":"172","text":"Portugal"},{"id":"173","text":"Puerto Rico"},{"id":"174","text":"Qatar"},{"id":"175","text":"Rwanda"},{"id":"176","text":"Reunion"},{"id":"177","text":"Romania"},{"id":"178","text":"Russian Federation"},{"id":"179","text":"Samoa"},{"id":"180","text":"San Marino"},{"id":"181","text":"Sao Tome and Principe"},{"id":"182","text":"Saudi Arabia"},{"id":"183","text":"Senegal"},{"id":"184","text":"Serbia"},{"id":"185","text":"Seychelles"},{"id":"186","text":"Sierra Leone"},{"id":"187","text":"Singapore"},{"id":"188","text":"Slovakia"},{"id":"189","text":"Slovenia"},{"id":"190","text":"Solomon Islands"},{"id":"191","text":"South Africa"},{"id":"192","text":"Spain"},{"id":"193","text":"Sri Lanka"},{"id":"194","text":"St. Helena"},{"id":"195","text":"Saint Kitts and Nevis"},{"id":"196","text":"Saint Lucia"},{"id":"197","text":"St. Pierre and Miquelon"},{"id":"198","text":"Saint Vincent and the Grenadines"},{"id":"199","text":"Sudan"},{"id":"200","text":"Suriname"},{"id":"201","text":"Svalbard"},{"id":"202","text":"Swaziland"},{"id":"203","text":"Sweden"},{"id":"204","text":"Switzerland"},{"id":"205","text":"Syria"},{"id":"206","text":"Taiwan"},{"id":"207","text":"Tajikistan"},{"id":"208","text":"Tanzania"},{"id":"209","text":"Thailand"},{"id":"210","text":"Togo"},{"id":"211","text":"Tokelau"},{"id":"212","text":"Tonga"},{"id":"213","text":"Trinidad and Tobago"},{"id":"214","text":"Tunisia"},{"id":"215","text":"Turkey"},{"id":"216","text":"Turkmenistan"},{"id":"217","text":"Turks and Caicos Islands"},{"id":"218","text":"Tuvalu"},{"id":"219","text":"Uganda"},{"id":"220","text":"Ukraine"},{"id":"221","text":"United Arab Emirates"},{"id":"222","text":"United Kingdom"},{"id":"223","text":"US Minor Outlying Islands"},{"id":"224","text":"Uruguay"},{"id":"225","text":"Uzbekistan"},{"id":"226","text":"Vanuatu"},{"id":"227","text":"Vatican City State"},{"id":"228","text":"Venezuela"},{"id":"229","text":"Viet Nam"},{"id":"230","text":"Virgin Islands (British)"},{"id":"231","text":"Virgin Islands, U.S."},{"id":"232","text":"Wallis and Futuna Islands"},{"id":"233","text":"Western Sahara"},{"id":"234","text":"Yemen"},{"id":"235","text":"Yugoslavia"},{"id":"236","text":"Zaire"},{"id":"237","text":"Zambia"},{"id":"238","text":"\u00c5land Islands"},{"id":"239","text":"Saint Barth\u00e9lemy"},{"id":"240","text":"Bonaire, Sint Eustatius and Saba"},{"id":"241","text":"Belarus"},{"id":"242","text":"Congo, the Democratic Republic of the"},{"id":"243","text":"Cura\u00e7ao"},{"id":"244","text":"Guernsey"},{"id":"245","text":"South Georgia and the South Sandwich Islands"},{"id":"246","text":"Isle of Man"},{"id":"247","text":"Jersey"},{"id":"248","text":"Myanmar"},{"id":"249","text":"Palestinian Territories"},{"id":"250","text":"Somalia"},{"id":"251","text":"South Sudan"},{"id":"252","text":"Sint Maarten (Dutch part)"},{"id":"253","text":"Zimbabwe"},{"id":"254","text":"Kosovo"},{"id":"255","text":"Kurdistan"},{"id":"256","text":"Saint Martin (French part)"}]},"linkedinUrl":{"isRequired":false,"value":"","label":"LinkedIn URL"},"dateAvailable":{"isRequired":false,"value":"","label":"Date Available"},"desiredPay":{"isRequired":false,"value":"","label":"Desired Pay"},"websiteUrl":{"isRequired":false,"value":"","label":"Website, Blog or Portfolio"},"resumeFileId":{"isRequired":true,"value":"","label":"Resume"},"customQuestions":[{"id":"268","isRequired":true,"question":"Do you hold a PhD in Pharmacology, Biology, Organic\/Medicinal Chemistry, or a related field?","type":"yes_no","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"269","isRequired":true,"question":"Do you have at least 7 years of post-PhD experience in the biotech\/pharmaceutical industry?","type":"yes_no","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"270","isRequired":true,"question":"Have you worked at a biotechnology or pharmaceutical company in the U.S. or Europe for a period of at least 2 years?","type":"yes_no","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"271","isRequired":true,"question":"Do you have direct experience managing external vendors for Targeted Protein Degradation (TPD), PROTACs, or Antibody-Drug Conjugates (ADCs)?","type":"yes_no","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"272","isRequired":true,"question":"Are you professionally fluent in both Mandarin and English (written and oral)?","type":"yes_no","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"273","isRequired":true,"question":"Briefly describe a time you managed a project at a large Chinese CRO (e.g., WuXi). How did you ensure your project remained a priority during a timeline or resource conflict?","type":"long","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"274","isRequired":true,"question":"Orum focuses on DACs (Degrader-Antibody Conjugates). In your view, what is the most significant challenge when transitioning a molecular glue payload from synthesis to conjugation with an antibody?","type":"long","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"275","isRequired":true,"question":"Why are you interested in being the 'first hire' in China for a Western biotech? What specific experience makes you comfortable operating in a self-managed, remote environment?","type":"long","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"276","isRequired":true,"question":"Are you currently based in China or willing to relocate immediately to a major hub (e.g., Shanghai\/Suzhou) to facilitate on-site vendor audits?","type":"yes_no","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"277","isRequired":true,"question":"Are you comfortable with a work schedule that requires regular evening or early morning calls to align with teams in Lexington (EST) and Daejeon (KST)?","type":"yes_no","value":"","isValueOther":false,"hasOther":"no","options":[]},{"id":"281","isRequired":false,"question":"Would you be able to travel to our Daejeon office in Korea for an onsite interview on short notice?","type":"short","value":"","isValueOther":false,"hasOther":"no","options":[]}],"genderId":[],"ethnicityId":[],"veteranStatusId":[],"disabilityId":[]}}}